Skip to search.
 FTSE 100 Up 0.71%

Alkermes plc (ALKS)

-NasdaqGS
58.15 Down 4.11(6.60%) 21:00
|After Hours: : 59.17 Up 1.02 (1.75%) 21:10
Add to Portfolio
Prev Close:62.26
Open:62.96
Bid:58.15 x 6800
Ask:58.17 x 600
1y Target Est:69.82
Beta:1.47
Next Earnings Date:30-Apr-15ALKS Earnings announcement
Day's Range:57.89 - 63.02
52wk Range:38.49 - 75.17
Volume:1,597,825
Avg Vol (3m):1,390,020
Market Cap:8.61b
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSDown 6.60%8.61b
ABTDown 1.72%71.66b
LLYDown 0.96%75.19b
GSKUp 0.56%112.70b

Key Statistics

Forward P/E (1 yr):2,907.50
P/S (ttm):14.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.39
Quarterly EPS Est (Mar-15) :-0.03
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-2.47

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback